Medlive Technology Co., Ltd. (2192.HK)
HKD 9.77
(-1.31%)
HKD 9.77
(-1.31%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 262.86 Million CNY | 82.21% |
| 2022 | 144.55 Million CNY | 88.07% |
| 2021 | 76.61 Million CNY | -29.69% |
| 2020 | 110.37 Million CNY | 153.84% |
| 2019 | 42.12 Million CNY | 103.77% |
| 2018 | 20.81 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 28.3 Million CNY | 0.0% |
| 2024 Q1 | 28.3 Million CNY | 19.93% |
| 2023 Q4 | 23.6 Million CNY | 0.0% |
| 2023 FY | - CNY | 82.21% |
| 2023 Q3 | 23.6 Million CNY | 116.19% |
| 2023 Q2 | 10.91 Million CNY | 0.0% |
| 2023 Q1 | 10.91 Million CNY | -58.3% |
| 2022 Q3 | 26.18 Million CNY | 460.19% |
| 2022 Q2 | 4.67 Million CNY | 0.0% |
| 2022 Q1 | 4.67 Million CNY | -66.02% |
| 2022 FY | - CNY | 88.07% |
| 2022 Q4 | 26.18 Million CNY | 0.0% |
| 2021 Q4 | 13.75 Million CNY | 0.0% |
| 2021 Q1 | 18.11 Million CNY | -42.82% |
| 2021 Q2 | 18.11 Million CNY | 0.0% |
| 2021 Q3 | 13.75 Million CNY | -24.05% |
| 2021 FY | - CNY | -29.69% |
| 2020 FY | - CNY | 153.84% |
| 2020 Q3 | 31.67 Million CNY | 47.9% |
| 2020 Q2 | 21.41 Million CNY | 0.0% |
| 2020 Q1 | 21.41 Million CNY | 0.0% |
| 2020 Q4 | 31.67 Million CNY | 0.0% |
| 2019 FY | - CNY | 103.77% |
| 2018 FY | - CNY | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Wanjia Group Holdings Limited | -29.02 Million HKD | 1005.647% |
| China Health Group Limited | -37.41 Million HKD | 802.488% |
| Tai United Holdings Limited | -1.18 Billion HKD | 122.179% |